Panackal Anil A, Imhof Alexander, Hanley Edward W, Marr Kieren A
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Emerg Infect Dis. 2006 Mar;12(3):403-8. doi: 10.3201/eid1203.050670.
Aspergillus ustus is a mold that rarely infects humans; only 15 systemic cases have been reported. We report the first outbreak of invasive infection caused by A. ustus among hematopoietic stem cell transplant (HSCT) recipients. Six patients with infections were identified; 3 infections each occurred in both 2001 and 2003. Molecular typing by using randomly amplified polymorphic DNA (RAPD) and antifungal drug susceptibility testing were performed on clinical and environmental isolates recovered from our hospital from 1999 to 2003. The highest overall attack rate in HSCT patients was 1.6%. The overall death rate was 50%, and death occurred within 8 days after diagnostic culture collection. Clinical isolates exhibited decreased susceptibility to antifungal drugs, especially azoles. RAPD and phylogenetic analysis showed genetic similarity between isolates from different patients. Based on the clustering of cases in space and time and molecular data, common-source acquisition of this unusual drug-resistant species is possible.
ustus曲霉是一种很少感染人类的霉菌;仅报告过15例系统性感染病例。我们报告了造血干细胞移植(HSCT)受者中首次由ustus曲霉引起的侵袭性感染暴发。确定了6例感染患者;2001年和2003年各有3例感染。对1999年至2003年从我院分离的临床和环境菌株进行了随机扩增多态性DNA(RAPD)分子分型和抗真菌药敏试验。HSCT患者的总体最高发病率为1.6%。总死亡率为50%,死亡发生在诊断性培养物采集后8天内。临床分离株对抗真菌药物,尤其是唑类药物的敏感性降低。RAPD和系统发育分析显示不同患者的分离株之间存在遗传相似性。基于病例在空间和时间上的聚集以及分子数据,这种不寻常的耐药菌株有可能通过共同来源获得。